Navigation Links
Life Extension® Announces Recruitment for Alzheimer's Clinical Trial in South Florida
Date:8/25/2011

FT. LAUDERDALE, Fla., Aug. 25, 2011 /PRNewswire/ -- Life Extension, a pioneer in the latest anti-aging research and integrative health therapies, while offering superior quality, research-backed dietary supplements, is actively recruiting participants for a free clinical trial to study the effects of natural supplements and an innovative medical therapy on Alzheimer's disease. Mild to moderate Alzheimer's patients (as diagnosed by their physician) are needed for a 17- to 18-week study. This study requires weekly visits to the office of the study's principal investigator located in the Fort Lauderdale area. Participants will receive blood tests, medical evaluations, blood pressure checks, and study medication and supplements at no cost.

The objective of Life Extension's new clinical trial is to measure the effects of weekly injections of Enbrel® (generic name etanercept), a commonly used medication for autoimmune disorders such as rheumatoid arthritis, and nutritional supplements that may help suppress the inflammatory factor implicated in the neuronal degeneration of Alzheimer's disease. Twenty million Americans today are destined to contract Alzheimer's disease, an affliction that robs memory, intelligence and eventually the most rudimentary cognitive abilities. The few medications currently approved to treat Alzheimer's symptoms produce only modest, short-term effects. Some patients cannot tolerate them at all.

Dr. Steven Hirsch, Director of Clinical Research at Life Extension, stated that "Up until now, a diagnosis of Alzheimer's disease meant one was destined to slowly be deprived of all cognitive function, a condition that tops the list of aging people's disease fears. This is the first clinical trial sponsored by Life Extension that will permit us to better understand Alzheimer's disease and how traditional medications, in conjunction with nutritional supplements, may affect its progress. We are seeking volunteers who meet the criteria for inclusion into the study in order to help future patients diagnosed with the disease."

To participate in this study register online or send an e-mail expressing your interest in participating in this study to: LEClinicalResearch@LifeExtension.com. For further information you may also call the Life Extension Clinical Research Department at (866) 517-4536.

About Life Extension

For more than 30 years, Life Extension has been a pioneer in funding and reporting the latest anti-aging research and integrative health therapies while offering superior-quality dietary supplements to consumers.  A trailblazer in the $26 billion U.S. dietary supplements industry, Life Extension's core mission is to extend the healthy human life span using an integrative approach and funding cutting-edge scientific research. For more information, visit www.lef.org, www.Twitter.com/LifeExtension, www.Facebook.com/LifeExtension and www.YouTube.com/LifeExtensionVideos.

Contact:
Jennifer Noel
RF|Binder for Life Extension
212-994-7502
Jennifer.noel@rfbinder.com


'/>"/>
SOURCE Life Extension
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Life Extension® Launches New Product Containing ChromaDexs pTeroPure® Pterostilbene
2. PDI Announces Renewal of Engagement for 7th Consecutive Season
3. Nutrastar Announces Adoption of Share Repurchase Program
4. ePharmaSolutions Announces the Deployment of its Enterprise Clinical Trial Portal for Two Global Biopharmaceutical Companies
5. CVS Caremark Corporation Announces New Share Repurchase Authorization for up to $4 Billion of Common Stock
6. ChemOutsourcing Announces the 62 Exhibitors to Present API & New Chemical Technologies at September 12-15, 2011 Show in NJ
7. VIVUS Announces $45.8 Million Registered Direct Offering of Common Stock
8. Concord Medical Services Holdings Announces Participation in Coming Investor Conferences
9. Avant Healthcare Marketing Announces West Coast Expansion
10. Elbit Imaging Ltd. Announces Interest Rate for the Next Interest Period for Series B Notes
11. China Nepstar Chain Drugstore Announces Share Repurchase Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... Dr. Vivek Ahuja , ... Ste phen Schmidt ... of cloud-based software solutions for life sciences, today announced key new ... wealth of insight to a growing business.  This will bolster the ... George Phillips joined ArisGlobal in the position of Vice President ...
(Date:4/28/2016)... MARLTON, N.J. , April 28, 2016   ... solutions, today announced that leading IT market research and ... Player " in the IDC MarketScape: Worldwide Pharmaceutical Track ... March 2016).  The report provides an assessment of the ... pharmaceutical track and trace software market. Logo ...
(Date:4/28/2016)... TapImmune,Inc. (TPIV), a clinical-stage ... gene-based immunotherapeutics and vaccines for the treatment of cancer & ... 3rd Annual Growth Capital Expo to be held ... Caesars Palace in Las Vegas, Nevada.  The Company presentation ... th by Dr. John N. Bonfiglio a ...
Breaking Medicine Technology:
(Date:4/28/2016)... ... ... In 2011, TIME magazine named Herr the “Leader of the Bionic Age”, because ... physiology with electromechanics. He continues that work as Director of the Biomechatronics research group ... a leader in the field of prosthetic devices. , After a blizzard during a ...
(Date:4/28/2016)... San Antonio, Texas (PRWEB) , ... April 28, 2016 , ... ... counseling, recently opened its newest office in San Antonio – its San Antonio West ... over 10 years in medical device sales. The grand opening of Amada San Antonio ...
(Date:4/28/2016)... MA (PRWEB) , ... April 28, 2016 , ... A ... were typical among 18 states studied, the Workers Compensation Research Institute (WCRI) ... The WCRI study, CompScope™ Benchmarks for Kentucky, 16th Edition , found that indemnity ...
(Date:4/28/2016)... WASHINGTON D.C. (PRWEB) , ... April 28, 2016 ... ... be receiving state-specific Pharmacy Discount Cards in the mail from USA Medical Prescription ... in each state. , Each mailed package will include a ready-to-use, ...
(Date:4/28/2016)... , ... April 28, 2016 , ... Boston Laser is ... and Drug Administration (FDA). The treatment consists of the application of Riboflavin, a vitamin, ... collagen fibers which in turn strengthens the cornea to slow the progression of keratoconus. ...
Breaking Medicine News(10 mins):